Featured Event

• 

  Webinar: ACT DMD Update with PTC

  February 5, 2014 from 1pm to 2pm – Online Webinar - Eastern Time Zone On February 5, 2014, Dr. Robert Spiegel, Chief Medical Officer at PTC Therapeutics, presented an update about PTC’s Phase 3 study of ataluren, now known as the Ataluren Confirmatory Trial in DMD (ACT… Organized by PPMD | Type: webinar